| 1 | [SID49667306] | Active | AC50 | 0.532 | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity [AID504725, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | AC50 | 0.532 [uM] | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity | | AID | 504725 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 2 | [SID49667306] | Active | AC50 | 1.072 | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504727, Type: confirmatory] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | AC50 | 1.072 [uM] | | BioAssay | C-LANA Counter Screen: DNA intercalators Measured in Biochemical System Using Plate Reader - 2117-02_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504727 | | BioAssay type | confirmatory | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 3 | [SID49667306] | Active | IC50 | 3.411 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase [AID2755, Type: confirmatory] | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 3.411 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput counterscreen to identify inhibitors of TEM-1 metallo-beta-lactamase | | AID | 2755 | | BioAssay type | confirmatory | | Target | Beta lactamase [Pseudomonas aeruginosa] [gi:114881106] | | PubMed | | | Data Table |  |
|
| 4 | [SID49667306] | Active | IC50 | 4.473 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 4.473 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 5 | [SID49667306] | Active | IC50 | 4.473 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase [AID2754, Type: confirmatory] | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 4.473 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of VIM-2 metallo-beta-lactamase | | AID | 2754 | | BioAssay type | confirmatory | | Target | metallo beta-lactamase [Pseudomonas aeruginosa] [gi:7381449] | | PubMed | | | Data Table |  |
|
| 6 | [SID49667306] | Active | IC50 | 8.62 | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase [AID2756, Type: confirmatory] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 8.62 [uM] | | BioAssay | Epi-absorbance-based dose response assay for common IMP-1 and VIM-2 inhibitors: biochemical high throughput screening assay to identify inhibitors of IMP-1metallo-beta-lactamase | | AID | 2756 | | BioAssay type | confirmatory | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 7 | [SID49667306] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 8 | [SID49667306] | Active | Potency | 19.9526 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 9 | [SID49667306] | Active | IC50 | 20.3 | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Mouse Intestinal Alkaline Phosphatase [AID488874, Type: confirmatory] | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 20.3 [uM] | | BioAssay | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Mouse Intestinal Alkaline Phosphatase | | AID | 488874 | | BioAssay type | confirmatory | | Target | intestinal alkaline phosphatase precursor [Mus musculus] [gi:124487323] | | PubMed | | | Data Table |  |
|
| 10 | [SID49667306] | Active | Potency | 23.0854 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 23.0854 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 11 | [SID49667306] | Active | Potency | 23.0854 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation [AID651600, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 23.0854 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation | | AID | 651600 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 12 | [SID49667306] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 13 | [SID49667306] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 14 | [SID49667306] | Active | IC50 | 28.1 | Dose Response confirmation of uHTS hits from a small molecule inhibitors of human intestinal alkaline phosphatase via a luminescent assay - Set 2 [AID488793, Type: confirmatory] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 28.1 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule inhibitors of human intestinal alkaline phosphatase via a luminescent assay - Set 2 | | AID | 488793 | | BioAssay type | confirmatory | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 15 | [SID49667306] | Active | IC50 | 28.1 | Dose Response confirmation of uHTS hits from a small molecule inhibitors of human intestinal alkaline phosphatase via a luminescent assay - Set 2 [AID488793, Type: confirmatory] | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 28.1 [uM] | | BioAssay | Dose Response confirmation of uHTS hits from a small molecule inhibitors of human intestinal alkaline phosphatase via a luminescent assay - Set 2 | | AID | 488793 | | BioAssay type | confirmatory | | Target | Alkaline phosphatase, intestinal [Homo sapiens] [gi:124376142] | | PubMed | | | Data Table |  |
|
| 16 | [SID49667306] | Active | IC50 | 29.9 | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase [AID488892, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 29.9 [uM] | | BioAssay | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase | | AID | 488892 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 17 | [SID49667306] | Active | IC50 | 29.9 | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase [AID488892, Type: confirmatory] | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 29.9 [uM] | | BioAssay | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Placental Alkaline Phosphatase | | AID | 488892 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, placental-like preproprotein [Homo sapiens] [gi:157266296] | | PubMed | | | Data Table |  |
|
| 18 | [SID49667306] | Active | IC50 | 34 | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. [AID488882, Type: confirmatory] | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 34 [uM] | | BioAssay | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. | | AID | 488882 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] | | PubMed | | | Data Table |  |
|
| 19 | [SID49667306] | Active | IC50 | 34 | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. [AID488882, Type: confirmatory] | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | IC50 | 34 [uM] | | BioAssay | Dose Response confirmation of uHTS inhibitors of Human Intestinal Alkaline Phosphatase using Tissue Nonspecific Alkaline Phosphatase. | | AID | 488882 | | BioAssay type | confirmatory | | Target | alkaline phosphatase, tissue-nonspecific isozyme isoform 1 precursor [Homo sapiens] [gi:116734717] | | PubMed | | | Data Table |  |
|
| 20 | [SID49667306] | Active | Potency | 36.5879 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay [AID651599, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 36.5879 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay | | AID | 651599 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 21 | [SID49667306] | Active | Potency | 36.5879 | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay [AID651599, Type: confirmatory] | TSG101 gene product [Homo sapiens] [gi:5454140] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 36.5879 [uM] | | BioAssay | qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101: Hit Validation in TR assay | | AID | 651599 | | BioAssay type | confirmatory | | Target | TSG101 gene product [Homo sapiens] [gi:5454140] | | PubMed | | | Data Table |  |
|
| 22 | [SID49667306] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 23 | [SID49667306] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 24 | [SID49667306] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 25 | [SID49667306] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 26 | [SID49667306] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 27 | [SID49667306] | Active | | | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) [AID624414, Type: screening] | MCOLN1 gene product [Homo sapiens] [gi:10092597] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | qHTS for Agonists of the Human Mucolipin Transient Receptor Potential 1 (TRPML1) | | AID | 624414 | | BioAssay type | screening | | Target | MCOLN1 gene product [Homo sapiens] [gi:10092597] | | PubMed | | | Data Table |  |
|
| 28 | [SID49667306] | Active | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 29 | [SID49667306] | Active | | | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity [AID602252, Type: screening] | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity | | AID | 602252 | | BioAssay type | screening | | Target | Golgi-associated PDZ and coiled-coil motif-containing protein isoform b [Homo sapiens] [gi:62868213] | | PubMed | | | Data Table |  |
|
| 30 | [SID49667306] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 31 | [SID49667306] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 32 | [SID49667306] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) [AID624466, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624466 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 33 | [SID49667306] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 34 | [SID49667306] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) [AID624467, Type: screening] | TAAR1 gene product [Homo sapiens] [gi:21264324] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1) | | AID | 624467 | | BioAssay type | screening | | Target | TAAR1 gene product [Homo sapiens] [gi:21264324] | | PubMed | | | Data Table |  |
|
| 35 | [SID49667306] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 36 | [SID49667306] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | NAD-dependent protein deacylase sirtuin-5, mitochondrial [gi:38258652] | | PubMed | | | Data Table |  |
|
| 37 | [SID49667306] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 38 | [SID49667306] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) [AID485272, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS) | | AID | 485272 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 39 | [SID49667306] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 40 | [SID49667306] | Active | | | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) [AID488796, Type: screening] | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of Protein Arginine Deiminase 4 (PAD4) | | AID | 488796 | | BioAssay type | screening | | Target | protein-arginine deiminase type-4 [Homo sapiens] [gi:216548487] | | PubMed | | | Data Table |  |
|
| 41 | [SID49667306] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 42 | [SID49667306] | Active | | | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity [AID504523, Type: screening] | KEAP1 gene product [Homo sapiens] [gi:45269145] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2 Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504523 | | BioAssay type | screening | | Target | KEAP1 gene product [Homo sapiens] [gi:45269145] | | PubMed | | | Data Table |  |
|
| 43 | [SID49667306] | Active | | | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. [AID493084, Type: screening] | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | qHTS for Small Molecule Agonists and Allosteric Enhancers of Human TRH Receptor: Primary Screen for Agonists. | | AID | 493084 | | BioAssay type | screening | | Target | thyrotropin-releasing hormone receptor [Homo sapiens] [gi:4507681] | | PubMed | | | Data Table |  |
|
| 44 | [SID49667306] | Active | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 45 | [SID49667306] | Active | | | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 [AID540275, Type: screening] | TRPV1 gene product [Homo sapiens] [gi:74315350] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | HTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1 | | AID | 540275 | | BioAssay type | screening | | Target | TRPV1 gene product [Homo sapiens] [gi:74315350] | | PubMed | | | Data Table |  |
|
| 46 | [SID49667306] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 47 | [SID49667306] | Active | | | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID652036, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput confirmation assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 652036 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 48 | [SID49667306] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 49 | [SID49667306] | Active | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant [AID1530, Type: screening] | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant | | AID | 1530 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase kinase 2 [Homo sapiens] [gi:22035600] | | PubMed | | | Data Table |  |
|
| 50 | [SID49667306] | Active | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) [AID493087, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49667306 | | CID | 3801816 | | Outcome | Active | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE) | | AID | 493087 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|